CRISPR gene editing technology
GPTKB entity
Statements (64)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:biotechnology
|
gptkbp:allows |
targeted gene modification
|
gptkbp:based_on |
gptkb:CRISPR-Cas9_system
|
gptkbp:business_model |
germline editing
genetic modification designer babies |
gptkbp:can_be_used_to |
study gene function
create genetically modified organisms develop gene therapies |
gptkbp:collaborated_with |
gptkb:scientists
universities research institutions |
gptkbp:developed_by |
gptkb:Emmanuelle_Charpentier
gptkb:Jennifer_Doudna |
gptkbp:enables |
gene replacement
gene insertion gene knockout |
gptkbp:has_applications_in |
crop improvement
disease treatment |
gptkbp:has_limitations |
off-target effects
regulatory hurdles delivery methods |
https://www.w3.org/2000/01/rdf-schema#label |
CRISPR gene editing technology
|
gptkbp:influences |
future of medicine
future of agriculture future of biotechnology |
gptkbp:is_advancing_in |
agricultural biotechnology
therapeutic applications industrial biotechnology |
gptkbp:is_applied_in |
gptkb:biotechnology
gptkb:Medicine agriculture |
gptkbp:is_associated_with |
biomedical research
genetic engineering molecular genetics |
gptkbp:is_challenged_by |
gptkb:political_debates
gptkb:public_opinion ethical dilemmas |
gptkbp:is_explored_in |
gptkb:literature
conferences patents |
gptkbp:is_part_of |
gptkb:biotechnology
molecular biology genomics |
gptkbp:is_popular_in |
universities
research institutions biotech companies |
gptkbp:is_promoted_by |
advocacy groups
scientific organizations biotech firms |
gptkbp:is_regulated_by |
government agencies
ethical committees |
gptkbp:is_subject_to |
regulatory scrutiny
legal challenges patent disputes |
gptkbp:is_supported_by |
gptkb:venture_capital
funding agencies government grants |
gptkbp:is_used_in |
clinical trials
agricultural research pharmaceutical development |
gptkbp:used_for |
genome editing
|
gptkbp:bfsParent |
gptkb:Science_magazine
|
gptkbp:bfsLayer |
5
|